ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Myocardial fibrosis and prognosis in heart failure with preserved ejection fraction: a pooled analysis of 12 cohort studies

Zhang, Xiaojie; Yang, Shaomin; Hao, Shali; Li, Jiahuan; Qiu, Min; Chen, Haixiong*; Huang, Yuli*南方医科大学; 1
European Radiology2023-9-2DOI: 10.1007/s00330-023-10218-w
12阅读
引用收藏
分享

摘要

ObjectivesHeart failure with preserved ejection fraction (HFpEF) is a syndrome with significant clinical heterogeneity. Myocardial fibrosis has been considered a common pathological process in the development and progress of HFpEF. This study aimed to consolidate data on the prognostic effect of myocardial fibrosis, evaluated by cardiovascular magnetic resonance (CMR) imaging in patients with HFpEF.MethodsThree medical databases were searched for potentially related articles up to February 28, 2023. Cohort studies reporting associations between myocardial fibrosis and risk of all-cause mortality or composite major adverse cardiac outcomes (MACE) were included. Cardiac fibrosis was evaluated by CMR metrics, including late gadolinium enhancement (LGE) or myocardial extracellular volume (ECV). The hazard ratios (HRs) and 95% confidence intervals (CI) of the outcomes for higher myocardial fibrosis were calculated.ResultsTwelve studies with 2787 patients with HFpEF were included for analysis. After a median follow-up duration of 31.2 months, a higher level of cardiac fibrosis was associated with a significant increase in the risk of MACE (HR = 1.34, 95% CI = 1.14-1.57) and all-cause mortality (HR = 1.74, 95% CI = 1.27-2.39), respectively. Furthermore, the increased risk of outcomes was both observed when cardiac fibrosis was defined according to LGE or ECV, respectively.ConclusionsHigher burden of myocardial fibrosis evaluated by CMR can predict a poor prognosis in patients with HFpEF. Evaluation of LGE or ECV based on CMR could be recommended in these patients for risk stratification and guiding further treatment.Clinical relevance statementInclusion of cardiovascular magnetic resonance examination in the diagnostic and risk-evaluation algorithms in patients with heart failure with preserved ejection fraction should be considered in clinical practice and future studies.Key Points & BULL; Myocardial fibrosis is a common pathological process in heart failure with preserved ejection fraction.& BULL; A higher myocardial fibrosis burden on cardiac magnetic resonance predicts a poor prognosis in patients with heart failure with preserved ejection fraction.& BULL; Evaluation of myocardial fibrosis may be useful in patients with heart failure with preserved ejection fraction for risk stratification and treatment guidance.Key Points & BULL; Myocardial fibrosis is a common pathological process in heart failure with preserved ejection fraction.& BULL; A higher myocardial fibrosis burden on cardiac magnetic resonance predicts a poor prognosis in patients with heart failure with preserved ejection fraction.& BULL; Evaluation of myocardial fibrosis may be useful in patients with heart failure with preserved ejection fraction for risk stratification and treatment guidance.Key Points & BULL; Myocardial fibrosis is a common pathological process in heart failure with preserved ejection fraction.& BULL; A higher myocardial fibrosis burden on cardiac magnetic resonance predicts a poor prognosis in patients with heart failure with preserved ejection fraction.& BULL; Evaluation of myocardial fibrosis may be useful in patients with heart failure with preserved ejection fraction for risk stratification and treatment guidance.

学科与关键词

关键词
Heart failureMagnetic resonance imagingAll-cause mortalityGadoliniumPrognosis
相关
加载中…
  • CMR to characterize myocardial structure and function in heart failure with preserved left ventricular ejection fraction
    Ipek, Rojda; Holland, Jennifer; Cramer, Mareike; Rider, Oliver*European Heart Journal-Cardiovascular Imaging, 2024, 25(11): 1491-1504.被引 1
  • A novel cardiac magnetic resonance-based personalized risk stratification model in dilated cardiomyopathy: a prospective study
    Zhou, Di; Zhu, Leyi; Wu, Weichun; Zhuang, Baiyan; He, Jian; Xu, Jing; Yang, Wenjing; Wang, Yining; Li, Shuang; Sun, Xiaoxin; Sharma, Piyush; Liu, Guanshu; Sirajuddin, Arlene; Arai, Andrew; Zhao, Shihua; Lu, Minjie*European Radiology, 2024, 34(6): 4053-4064.被引 1
  • Detection of myocardial fibrosis: Where we stand
    Zhu, Leyi; Wang, Yining; Zhao, Shihua; Lu, Minjie*Frontiers in Cardiovascular Medicine, 2022, 9: 926378.被引 5
查看全部 →

发表信息

论文状态
公开发表
期刊
European Radiology
发表日期
2023-09-02
DOI
10.1007/s00330-023-10218-w
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82270384]; Guangdong Basic and Applied Basic Research Fund (Key project of Guangdong-Foshan Joint Fund) [2019B1515120044]; Scientific Research Start-up Plan of Southern Medical University [CX2018N202]; Clinical Research Startup Program of Shunde Hospital, Southern Medical University [CRSP2019001]; Outstanding Young Medical Staff in Guangdong Province [600001]

作者

  • Z

    Zhang, Xiaojie (第一作者)

    1 · southern med univ

  • Y

    Yang, Shaomin

查看全部 7 位作者收起作者
  • H

    Hao, Shali

    1 · southern med univ

  • L

    Li, Jiahuan

    1 · southern med univ

  • Q

    Qiu, Min

    1 · southern med univ

  • C

    Chen, Haixiong (通讯)

    1 · southern med univ

  • H

    Huang, Yuli (通讯)

    new · 1 · southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417